Cryoport Stock Forecast, Price & News

Cryoport (NASDAQ:CYRX) Frequently Asked Questions

Is Cryoport a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cryoport stock.
View analyst ratings for Cryoport or view top-rated stocks.

How has Cryoport's stock price been impacted by Coronavirus (COVID-19)?

Cryoport's stock was trading at $16.62 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CYRX shares have increased by 157.6% and is now trading at $42.81.
View which stocks have been most impacted by COVID-19.

When is Cryoport's next earnings date?

Cryoport is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for Cryoport.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) announced its quarterly earnings results on Thursday, November, 4th. The consumer goods maker reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of ($0.15) by $0.03. The consumer goods maker earned $56.69 million during the quarter, compared to analysts' expectations of $54.44 million. Cryoport had a negative net margin of 12.57% and a positive trailing twelve-month return on equity of 2.67%. The firm's revenue for the quarter was up 407.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.29) EPS.
View Cryoport's earnings history.

What price target have analysts set for CYRX?

7 analysts have issued 12-month target prices for Cryoport's shares. Their forecasts range from $75.00 to $95.00. On average, they expect Cryoport's share price to reach $87.14 in the next year. This suggests a possible upside of 103.6% from the stock's current price.
View analysts' price targets for Cryoport or view top-rated stocks among Wall Street analysts.

Who are Cryoport's key executives?

Cryoport's management team includes the following people:

• Jerrell W. Shelton, Chairman, President & Chief Executive Officer (LinkedIn Profile)
• Phil Wilson, Chief Operating Officer
• Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer (LinkedIn Profile)
• Bret Bollinger, Chief Technology Officer
• Mark W. Sawicki, Chief Scientific Officer (LinkedIn Profile)

Who are some of Cryoport's key competitors?

Some companies that are related to Cryoport include Biohaven Pharmaceutical (BHVN), Maravai LifeSciences (MRVI), Evotec (EVTCY), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), Mirati Therapeutics (MRTX), Arena Pharmaceuticals (ARNA), Arrowhead Pharmaceuticals (ARWR), Sarepta Therapeutics (SRPT), Perrigo (PRGO), HUTCHMED (HCM), Zai Lab (ZLAB), Ultragenyx Pharmaceutical (RARE), Blueprint Medicines (BPMC) and Ionis Pharmaceuticals (IONS).
View all of CYRX's competitors.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Square (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by many different retail and institutional investors. Top institutional investors include Spence Asset Management (0.30%), Penbrook Management LLC (0.07%), Lindbrook Capital LLC (0.00%) and Cutler Group LP (0.00%). Company insiders that own Cryoport stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for Cryoport.

Which major investors are selling Cryoport stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Penbrook Management LLC, and Cutler Group LP. Company insiders that have sold Cryoport company stock in the last year include Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for Cryoport or view top insider-selling stocks.

Which major investors are buying Cryoport stock?

CYRX stock was bought by a variety of institutional investors in the last quarter, including Spence Asset Management, and Lindbrook Capital LLC.
View insider buying and selling activity for Cryoport or or view top insider-buying stocks.

How do I buy shares of Cryoport?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $42.81.

How much money does Cryoport make?

Cryoport has a market capitalization of $1.98 billion and generates $78.70 million in revenue each year. The consumer goods maker earns $-32.69 million in net income (profit) each year or ($1.79) on an earnings per share basis.

How many employees does Cryoport have?

Cryoport employs 610 workers across the globe.

What is Cryoport's official website?

The official website for Cryoport is www.cryoport.com.

Where are Cryoport's headquarters?

Cryoport is headquartered at 112 Westwood Place Suite 350, Brentwood TN, 37027.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at (949) 470-2300, via email at [email protected], or via fax at 949-470-2306.